Bionomics Limited
NASDAQ:BNOX
0.38 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -15.492 | -21.212 | -15.023 | -6.521 | -4.913 | -7.274 | -18.567 | -5.188 | -12.361 |
| Depreciation & Amortization
| 0.663 | 0.771 | 0.766 | 1.275 | 1.497 | 1.006 | 1.234 | 1.339 | 1.443 |
| Deferred Income Tax
| -139.173 | -0.139 | -0.139 | -0.14 | -0.167 | -0.171 | -0.825 | -0.161 | -0.306 |
| Stock Based Compensation
| 0.815 | 1.905 | 2.83 | 1.308 | 0.055 | 0 | 0 | 0.387 | 0.298 |
| Change In Working Capital
| 1.455 | 0.033 | -0.027 | 0.026 | -0.159 | -0.21 | 0.428 | 0.04 | -0.314 |
| Accounts Receivables
| 0.299 | 0.033 | -0.027 | 0.026 | -0.14 | -0.103 | 0.475 | 0.032 | -0.282 |
| Inventory
| 0 | -4.792 | 3.895 | 0.153 | -0.02 | -0.107 | -0.048 | 0.009 | -0.031 |
| Accounts Payables
| 0.804 | 0.48 | 0.711 | -0.047 | 0.085 | -1.012 | 1.695 | -1.495 | -0.341 |
| Other Working Capital
| 0.351 | 4.312 | -4.606 | -0.106 | -0.085 | 1.012 | -0 | -0.11 | 0.409 |
| Other Non Cash Items
| -2.121 | 5.063 | -2.551 | -1.274 | 1.001 | -4.317 | 2.194 | 2.742 | -0.525 |
| Operating Cash Flow
| -14.681 | -14.216 | -15.02 | -5.653 | -2.694 | -10.939 | -15.138 | -1.107 | -11.442 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -0 | 0 | -0.001 | -0.001 | -0.005 | -0.069 | -0.361 | -0.19 | -0.147 |
| Acquisitions Net
| 0 | 0 | 0.127 | 0.027 | -0.499 | 0.01 | 0 | 0 | 0.05 |
| Purchases Of Investments
| 0 | 0 | -0.443 | -0.088 | -0.035 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0.316 | 0.062 | 0.369 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0.319 | 0.43 | -0.059 | 0.035 | 0.198 | 0.421 | 0.923 | 0.969 |
| Investing Cash Flow
| 0 | 0.319 | 0.429 | -0.06 | -0.135 | 0.139 | 0.06 | 0.733 | 0.823 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | -0.107 | -0.12 | -8.898 | -5.719 | -3.74 | -0.114 | -1.787 | -0.602 |
| Common Stock Issued
| 10.112 | 3.845 | 19.703 | 32.389 | 1.964 | 6.922 | 0.319 | 0.108 | 20.537 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0.415 | -0.048 | -0.42 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.997 | 3.701 | 18.638 | 23.661 | -3.697 | 3.055 | 1.95 | -1.599 | 24.734 |
| Financing Cash Flow
| 15.109 | 3.701 | 18.638 | 23.661 | -3.697 | 3.055 | 1.95 | -1.599 | 24.734 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.077 | -0.005 | -0.55 | -0.01 | 0.033 | 0.061 | -0.152 | -0.008 | -0.007 |
| Net Change In Cash
| 0.505 | -11.018 | 1.803 | 18.211 | -6.659 | -8.633 | -14.5 | -0.907 | 13.454 |
| Cash At End Of Period
| 12.687 | 12.155 | 23.174 | 21.37 | 3.159 | 9.819 | 18.452 | 32.952 | 33.859 |